Ryo Akihide, Liou Yih-Cherng, Wulf Gerburg, Nakamura Masafumi, Lee Sam W, Lu Kun Ping
Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Mol Cell Biol. 2002 Aug;22(15):5281-95. doi: 10.1128/MCB.22.15.5281-5295.2002.
Oncogenes Neu/HER2/ErbB2 and Ras can induce mammary tumorigenesis via upregulation of cyclin D1. One major regulatory mechanism in these oncogenic signaling pathways is phosphorylation of serines or threonines preceding proline (pSer/Thr-Pro). Interestingly, the pSer/Thr-Pro motifs in proteins exist in two completely distinct cis and trans conformations, whose conversion is catalyzed specifically by the essential prolyl isomerase Pin1. By isomerizing pSer/Thr-Pro bonds, Pin1 can regulate the conformation and function of certain phosphorylated proteins. We have previously shown that Pin1 is overexpressed in breast tumors and positively regulates cyclin D1 by transcriptional activation and posttranslational stabilization. Moreover, in Pin1 knockout mice, mammary epithelial cells fail to undergo massive proliferation during pregnancy, as is the case in cyclin D1 null mice. These results indicate that Pin1 is upregulated in breast cancer and may be involved in mammary tumors. However, the mechanism of Pin1 overexpression in cancer and its significance in cell transformation remain largely unknown. Here we demonstrate that PIN1 expression is mediated by the transcription factor E2F and enhanced by c-Neu and Ha-Ras via E2F. Furthermore, overexpression of Pin1 not only confers transforming properties on mammary epithelial cells but also enhances the transformed phenotypes of Neu/Ras-transformed mammary epithelial cells. In contrast, inhibition of Pin1 suppresses Neu- and Ras-induced transformed phenotypes, which can be fully rescued by overexpression of a constitutively active cyclin D1 mutant that is refractory to the Pin1 inhibition. Thus, Pin1 is an E2F target gene that is essential for the Neu/Ras-induced transformation of mammary epithelial cells through activation of cyclin D1.
癌基因Neu/HER2/ErbB2和Ras可通过上调细胞周期蛋白D1诱导乳腺肿瘤发生。这些致癌信号通路中的一个主要调节机制是脯氨酸之前的丝氨酸或苏氨酸的磷酸化(pSer/Thr-Pro)。有趣的是,蛋白质中的pSer/Thr-Pro基序以两种完全不同的顺式和反式构象存在,其转换由必需的脯氨酰异构酶Pin1特异性催化。通过异构化pSer/Thr-Pro键,Pin1可以调节某些磷酸化蛋白的构象和功能。我们之前已经表明,Pin1在乳腺肿瘤中过表达,并通过转录激活和翻译后稳定作用正向调节细胞周期蛋白D1。此外,在Pin1基因敲除小鼠中,乳腺上皮细胞在怀孕期间无法像细胞周期蛋白D1基因敲除小鼠那样进行大量增殖。这些结果表明,Pin1在乳腺癌中上调,并可能参与乳腺肿瘤的发生。然而,Pin1在癌症中过表达的机制及其在细胞转化中的意义仍然很大程度上未知。在这里,我们证明PIN1的表达由转录因子E2F介导,并通过E2F被c-Neu和Ha-Ras增强。此外,Pin1的过表达不仅赋予乳腺上皮细胞转化特性,还增强了Neu/Ras转化的乳腺上皮细胞的转化表型。相反,抑制Pin1可抑制Neu和Ras诱导的转化表型,而过表达对Pin1抑制具有抗性的组成型活性细胞周期蛋白D1突变体可完全挽救这种表型。因此,Pin1是一个E2F靶基因,通过激活细胞周期蛋白D1对Neu/Ras诱导的乳腺上皮细胞转化至关重要。